Published in Cell Growth Differ on November 01, 1998
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer (2004) 1.07
Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol Biol Cell (1999) 0.93
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer. Neoplasia (2009) 0.92
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion. Br J Cancer (2001) 0.91
The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target. Urol Oncol (2008) 0.87
Platelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer. PLoS One (2014) 0.86
Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells. Prostate (2010) 0.78
Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol (1999) 1.49
Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res (2001) 1.42
Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res (1996) 1.38
Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res (1999) 1.18
The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ (2011) 1.10
The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer (1991) 1.08
Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. Cancer Res (1995) 1.08
Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer (1991) 1.00
Regulation of c-jun expression during hypoxic and low-glucose stress. Mol Cell Biol (1994) 0.96
Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer (1998) 0.96
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer (1997) 0.96
The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats. Clin Cancer Res (2001) 0.91
Oxygen regulated 80 kDa protein and glucose regulated 78kDa protein are identical. Mol Cell Biochem (1991) 0.87
Specificity of xanthine oxidase for nitrogen heteroaromatic cation substrates. Can J Biochem (1980) 0.86
Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide. Biochem Pharmacol (1986) 0.86
A Xenopus homebox gene defines dorsal-ventral domains in the developing brain. Development (1993) 0.85
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay. Int J Radiat Oncol Biol Phys (1996) 0.83
Synergistic interaction between tirapazamine and cyclophosphamide in human breast cancer xenografts. Cancer Res (1994) 0.83
The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis (1998) 0.83
Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement. Biotechniques (2000) 0.83
Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res (1994) 0.82
Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids. Cancer Res (1993) 0.82
Early prostate-specific antigen failure following radical perineal versus retropubic prostatectomy: the importance of seminal vesicle excision. Urology (1998) 0.81
Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts. BMC Biotechnol (2001) 0.80
The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells. Growth Factors (2001) 0.75
The production of strand breaks in DNA in the presence of the hydroxylamine of SR-2508 (1-[N-(2-hydroxyethyl)acetamido]-2-nitroimidazole) at neutral pH. Int J Radiat Oncol Biol Phys (1986) 0.75
The pH dependence of xanthine oxidase catalysis in basic solution. Can J Biochem (1980) 0.75
Oncocidin A1: a novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice. Biochem Pharmacol (1998) 0.75